NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17 | +13.3% | 860 | +45.3% | 0.00% | – |
Q2 2023 | $15 | -28.6% | 592 | +2.2% | 0.00% | – |
Q1 2023 | $21 | -22.2% | 579 | -15.1% | 0.00% | – |
Q4 2022 | $27 | -99.9% | 682 | -2.8% | 0.00% | – |
Q3 2022 | $33,000 | -2.9% | 702 | -10.1% | 0.00% | – |
Q2 2022 | $34,000 | -38.2% | 781 | +3.2% | 0.00% | – |
Q1 2022 | $55,000 | +17.0% | 757 | +29.6% | 0.00% | – |
Q4 2021 | $47,000 | – | 584 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |